This inventor holds 8 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignee: Omeros Corporation. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2022
Title: Innovations by George A. Gaitanaris
Introduction
George A. Gaitanaris is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of addiction treatment. With a total of 8 patents to his name, Gaitanaris has focused on developing innovative solutions for impulse-control disorders and addiction.
Latest Patents
Among his latest patents is a groundbreaking method for the treatment of addiction and impulse-control disorders using phosphodiesterase 7 (PDE7) inhibitors. This disclosure outlines the use of PDE7 inhibitors, either alone or in combination with other therapeutic agents, to address these challenging conditions. His work in this area has the potential to transform treatment options for individuals struggling with addiction.
Career Highlights
Gaitanaris has made a significant impact in the pharmaceutical industry through his role at Omeros Corporation. His expertise in the development of therapeutic agents has positioned him as a key figure in the fight against addiction and impulse-control disorders.
Collaborations
Some of his notable coworkers include Gregory A. Demopulos and John E. Bergmann, who have collaborated with Gaitanaris on various projects aimed at advancing treatment methodologies.
Conclusion
George A. Gaitanaris continues to be a leading innovator in the field of addiction treatment, with his patents paving the way for new therapeutic approaches. His work exemplifies the importance of innovation in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile